Search - tctmd.com

Displaying 561 - 580 of 4055

Sort: Relevancy | Date

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Caitlin E. Cox

November 12, 2023

News Conference News AHA 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

Todd Neale

November 12, 2023

News Conference News AHA 2023

Leadless Pacemaker Prototype Uses Heart’s Energy to Partly Power Device

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Daily News

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

Michael O'Riordan

November 02, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Daily News

AHA Throws Its Support Behind New, Independent Medical Board

Michael O'Riordan

October 30, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Presenter: Jose Carlos Gonzalez Gutiérrez

October 26, 2023

Advertisement

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

Leadless Pacemaker Prototype Uses Heart’s Energy to Partly Power Device

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

New Carotid Stent Systems Associated With Low Stroke Risk

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

FDA Approves Paradise Renal Denervation System: What Comes Next?

What’s Going to Be Hot at AHA 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

November 2023 News Roundup

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

TCTMD’s Top 10 Most Popular Stories for October 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

AHA Throws Its Support Behind New, Independent Medical Board

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content